Swan Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$144K Buy
589
+57
+11% +$13.3K 0.05% 45
2025
Q4
$110K Hold
532
0.04% 53
2025
Q3
$98.6K Sell
532
-214
-29% -$36.7K 0.04% 55
2025
Q2
$114K Buy
746
+38
+5% +$5.84K 0.05% 47
2025
Q1
$117K Hold
708
0.05% 45
2024
Q4
$102K Hold
708
0.05% 48
2024
Q3
$115K Sell
708
-26
-4% -$4.14K 0.06% 48
2024
Q2
$107K Buy
+734
New +$109K 0.06% 45

Other funds holding JNJ

Swan Capital's JNJ Position: Q1 2026 in Review

Swan Capital increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $13.3K and bringing the position to 589 shares worth $144K. The position accounts for 0.05% of the portfolio, ranked #45.

Swan Capital first reported a position in JNJ in Q2 2024 and has held it in 8 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Swan Capital held 589 shares of Johnson & Johnson worth $144K as of Q1 2026.
  • Swan Capital bought 57 Johnson & Johnson shares in Q1 2026, an estimated $13.3K.
  • Johnson & Johnson made up 0.05% of Swan Capital's portfolio in Q1 2026, its #45 holding.
  • Swan Capital first reported a position in Johnson & Johnson in Q2 2024 and has held it in 8 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.